How Biologics Teams Use Dynamic Light Scattering To Identify Leading Candidates

Groups in early biologics development and formulation use Dynamic Light Scattering (DLS) to make informed decisions that de-risk downstream biologics development.

Watch this 15 min overview of how DLS works and how it improves these biologics development processes.

You'll learn:

• What DLS measures and how it works during a quick refresher
• What DLS data tells you about your biologics
• How DLS data from samples with strong or poor colloidal stability looks like
• How to use DLS to remove candidates with no promise so you can focus on candidates and conditions that have potential

At the end, you'll understand how and when you can add DLS to your early development workflow to de-risk candidate selection.

Why it's important for biologics researchers:

A successful biologic candidate screening campaign depends on having the right tools. When tasked with identifying the most promising biologics candidates, adding DLS gives you more detailed and reliable insights into the purity and colloidal stability of your samples.